---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-016427"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2023-05-02T23:59:59+00:00"
generated_at: "2026-06-16T04:23:59.962415+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q1 net rev $491M, GAAP EPS $0.17, adj EPS $0.23, reaffirms FY adj EBITDA $235-245M

## Summary
- Net revenue $491M, up 1.8% YoY; same-unit revenue up 2.0% driven by volume and collections.
- GAAP EPS $0.17; adjusted EPS $0.23; prior year adjusted EPS $0.33 (incl $0.07 CARES benefit).
- Adjusted EBITDA $40.1M vs $50.7M YoY; FY 2023 guidance reaffirmed at $235-245M.
- Cash used in ops $100.6M; total debt $752M; share count decreased due to 2022 buybacks.
- No CARES Act revenue recorded in Q1 2023 vs $10.4M in Q1 2022.

## SEC filing metadata
- accession: 0000950170-23-016427
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2023-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017023016427/0000950170-23-016427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017023016427/md-20230502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-016427
- JSON: https://secwatch.observer/filing/0000950170-23-016427.json
- Plain text: https://secwatch.observer/filing/0000950170-23-016427.txt

## Key facts
- Earnings Releases
  Pediatrix Medical Group, Inc. reported the three months ended March 31, 2023 results: revenue $491 million, net income $14 million, EPS $0.17 per share.
  - Period: the three months ended March 31, 2023
  - Revenue: $491 million
  - Net income: $14 million
  - EPS: $0.17 per share
  - Result: reported results
  source text: Pediatrix Medical Group, Inc. (NYSE: MD) , the nation’s leading provider of highly specialized health care for women, children and babies , today reported earnings from continuing operations of $0.17 per share for the three months ended March 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.23. For the 2023 first quarter, Pediatrix reported the following results from continuing operations: • Net revenue of $491 million; • Income from continuing operations of $14 million; and • Adjusted EBITDA of $40 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000095017023016427/0000950170-23-016427-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.